Cummings 1989.
Methods | Double‐blind randomised controlled trial | |
Participants | 36 two‐week‐old infants < 1251 grams birth weight, < 31 weeks, needing mechanical ventilation and > 29% oxygen at entry Exclusions: PDA, renal failure, sepsis Infants in control group received a saline placebo. |
|
Interventions | Dexamethasone 0.5 mg/kg/d for 3 days, 0.3 mg/kg/d for 3 days, then reduced by 10% every 3 days to 0.1 mg/kg/d for 3 days, then alternate days for 2 days or 0.5 mg/kg/d for 3 days, reduced by 50% every 3 days to 0.06 mg/kg/d for 3 days, then alternate days for 7 days | |
Outcomes | Durations of intermittent positive‐pressure ventilation (IPPV), oxygen, and hospital stay; rates of pneumothorax, hyperglycaemia, sepsis, GI bleeding, transfusions, ROP, mortality; growth and development. | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Randomised allocation to 1 of 3 groups via a table of random numbers kept in the pharmacy |
Allocation concealment (selection bias) | Low risk | Randomised allocation to 1 of 3 groups via a table of random numbers kept in the pharmacy Blinding of randomisation: yes |
Blinding (performance bias and detection bias) All outcomes | Low risk | Blinding of intervention: yes |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Blinding of intervention: yes |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Blinding of outcome measurement: yes |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Complete follow‐up: yes Blinding of outcome measurement: yes |
Selective reporting (reporting bias) | Unclear risk | All prespecified outcomes reported |